Rofecoxib as an alternative in aspirin hypersensitivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 8, 2001, Pages 789-

  Hinrichs, R ^a   Ritzkowsky, A ^a   Hunzelmann, N ^a   Krieg, T ^a   Scharffetter Kochanek, K ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Aspirin intolerance; Cyclooxygenase 2 inhibitor; NSAID; Rofecoxib; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CONJUNCTIVITIS; DRUG EFFECT; DRUG HYPERSENSITIVITY; DYSPNEA; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL; URTICARIA;

ADULT; ASPIRIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; HUMANS; ISOENZYMES; LACTONES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RETREATMENT; SULFONES;

EID: 0034912860     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.056008789.x     Document Type: Article

References (4)

1. NSAIDS intolerance: Clinical and diagnostic aspects
2. 4 synthase: A candidate gene for the aspirin-intolerant phenotype
3. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics
4. Celecoxib in patients with asthma and aspirin intolerance